U.S. Approves Bristol-Myers Squibb’s $430 Million Purchase of Adnexus Therapeutics

October 12, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, Oct 12 (Reuters) - U.S. antitrust officials have approved Bristol-Myers Squibb Co's (BMY.N: Quote, Profile, Research) purchase of Adnexus Therapeutics Inc, the Federal Trade Commission said on Friday.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Mergers & acquisitions

Bristol Myers Squibb Company